BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6186368)

  • 1. Effects of iron, copper, cobalt, and their chelators on the cytotoxicity of bleomycin.
    Lin PS; Kwock L; Hefter K; Misslbeck G
    Cancer Res; 1983 Mar; 43(3):1049-53. PubMed ID: 6186368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of metals and their antagonists on the radical intensity and cytotoxicity of ascorbates.
    Satoh K; Ida Y; Kochi M; Tajima M; Kashimata M; Sakagami H
    Anticancer Res; 1997; 17(5A):3355-60. PubMed ID: 9413172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The iron chelating cardioprotective prodrug dexrazoxane does not affect the cell growth inhibitory effects of bleomycin.
    Wu X; Patel D; Hasinoff BB
    J Inorg Biochem; 2004 Nov; 98(11):1818-23. PubMed ID: 15522409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diethyldithiocarbamate concentration effects and interactions with other cytotoxic agents on Chinese Hamster cells (V79).
    Lin PS; Quamo S; Ho KC; Baur K
    Radiat Res; 1985 Jun; 102(3):271-82. PubMed ID: 2416001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth-modulating tripeptide (glycylhistidyllysine): association with copper and iron in plasma, and stimulation of adhesiveness and growth of hepatoma cells in culture by tripeptide-metal ion complexes.
    Pickart L; Thaler MM
    J Cell Physiol; 1980 Feb; 102(2):129-39. PubMed ID: 6246126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of antioxidants and hyperthermia enhance bleomycin-induced cytotoxicity and lipid peroxidation in Chinese hamster ovary cells.
    Khadir A; Verreault J; Averill DA
    Arch Biochem Biophys; 1999 Oct; 370(2):163-75. PubMed ID: 10510274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin.
    Georgiou NA; van der Bruggen T; Oudshoorn M; Nottet HS; Marx JJ; van Asbeck BS
    J Infect Dis; 2000 Feb; 181(2):484-90. PubMed ID: 10669330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB; Lovejoy DB; Watts RN; Richardson DR
    Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron at the cell surface controls DNA synthesis in CCl 39 cells.
    Alcain FJ; Löw H; Crane FL
    Biochem Biophys Res Commun; 1994 Aug; 203(1):16-21. PubMed ID: 8074650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naringin, a grapefruit flavanone, protects V79 cells against the bleomycin-induced genotoxicity and decline in survival.
    Jagetia A; Jagetia GC; Jha S
    J Appl Toxicol; 2007; 27(2):122-32. PubMed ID: 17177233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of ascorbate solution by chelating agents that block redox cycling of metal ions.
    Nishikimi M; Ozawa T
    Biochem Int; 1987 Jan; 14(1):111-7. PubMed ID: 3566770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthermia and bleomycin schedules on V79 Chinese hamster cell cytotoxicity in vitro.
    Lin PS; Hefter K; Jones M
    Cancer Res; 1983 Oct; 43(10):4557-61. PubMed ID: 6192905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between sites of binding to DNA and strand cleavage for complexes of bleomycin with iron or cobalt.
    McLean MJ; Dar A; Waring MJ
    J Mol Recognit; 1989 Apr; 1(4):184-92. PubMed ID: 2483675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper chelator enhancement of bleomycin cytotoxicity.
    Lin PS; Kwock L; Goodchild NT
    Cancer; 1980 Dec; 46(11):2360-4. PubMed ID: 6159962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chelators controlling metal metabolism and toxicity pathways: applications in cancer prevention, diagnosis and treatment.
    Kontoghiorghes GJ; Efstathiou A; Ioannou-Loucaides S; Kolnagou A
    Hemoglobin; 2008; 32(1-2):217-27. PubMed ID: 18274999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antimicrobial drugs on the cytotoxicity of epirubicin, bleomycin, estramustine and cisplatin.
    Bergström P; Grankvist K; Holm S; Henriksson R
    Anticancer Res; 1991; 11(3):1039-43. PubMed ID: 1716083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of heat sensitivity and modification of repair of potentially lethal heat damage in plateau-phase cultures of mammalian cells by diethyldithiocarbamate.
    Evans RG; Nielsen J; Engel C; Wheatley C
    Radiat Res; 1983 Feb; 93(2):319-25. PubMed ID: 6296911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of iron in the cytotoxicity of tumor necrosis factor.
    Warren S; Torti SV; Torti FM
    Lymphokine Cytokine Res; 1993 Apr; 12(2):75-80. PubMed ID: 8324080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron chelators deferoxamine and diethylenetriamine pentaacetic acid induce apoptosis in ovarian carcinoma.
    Brard L; Granai CO; Swamy N
    Gynecol Oncol; 2006 Jan; 100(1):116-27. PubMed ID: 16203029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metallobleomycin-DNA interactions: structures and reactions related to bleomycin-induced DNA damage.
    Petering DH; Mao Q; Li W; DeRose E; Antholine WE
    Met Ions Biol Syst; 1996; 33():619-48. PubMed ID: 8742858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.